腹膜透析患者慢性肾脏病相关瘙痒的患病率与结局:国际PDOPPS研究
该研究基于2014至2022年PDOPPS国际多中心队列,纳入8国5535例腹膜透析患者,评估瘙痒患病率及其与患者报告结局和死亡/转血液透析的关联。结果显示43%患者存在中度至极重度瘙痒,瘙痒与较差生活质量及复合终点风险升高相关。
要点
- 腹膜透析患者中度至极重度瘙痒患病率达43%,泰国最高50%,美国最低33%。
- 极度瘙痒患者心理与躯体健康评分最低,不宁腿和睡眠障碍负担更高。
- 中度至极重度瘙痒与死亡或转血液透析复合风险升高独立相关(aHR 1.12)。
核心结论
- 腹膜透析患者中瘙痒高度流行,且与不良健康结局相关,需加强识别与管理。
研究设计与样本
- 多中心国际队列研究,分析2014至2022年PDOPPS中8国5535例腹膜透析患者。
主要发现
- 43%患者有中度至极重度瘙痒,泰国50%最高,美国33%最低。
- 极度瘙痒患者心理与躯体健康成分评分最低,不宁腿和睡眠障碍等负担更高。
- 中度至极重度瘙痒与死亡或转血液透析复合风险升高相关(aHR 1.12;95%CI 1.02-1.23;P=0.02)。
- 糖尿病、低白蛋白和高磷与中度至极重度瘙痒调整后OR升高相关;24小时尿量每增加200ml调整后OR为0.98(95%CI 0.96-1.00;P=0.05)。
关键数值与推荐
- 瘙痒采用单问题Likert量表评估,1分为完全不困扰,5分为极度困扰。
- 中度至极重度瘙痒定义为Likert评分≥3。
- 共921例死亡,1150例转血液透析。
临床怎么用
- 在腹膜透析随访中应常规筛查瘙痒,尤其关注糖尿病、低白蛋白、高磷及尿量较少者。
- 对中度至极重度瘙痒患者应评估生活质量、睡眠及不宁腿,并加强管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: CKD-associated pruritus is highly prevalent among peritoneal dialysis patients. Pruritus is associated with reduced health-related quality of life, and the composite of mortality and transfer to hemodialysis for peritoneal dialysis patients. Efforts to better identify and manage pruritus in this population are needed. BACKGROUND: Pruritus is common in hemodialysis patients. Less is known about the prevalence and outcomes of pruritus among patients receiving peritoneal dialysis (PD). Herein, we describe the prevalence of pruritus and its associations with patient-reported outcomes (PROs) and mortality/transfer to hemodialysis. METHODS: We analyzed a multicenter, international cohort of PD patients enrolled in the PD Outcomes and Practice Patterns Study from 2014 to 2022. Pruritus was assessed at entry into the PD Outcomes and Practice Patterns Study with a single-question Likert Scale capturing the extent to which patients were bothered by itch ranging from 1: not at all to 5: extremely. The kidney disease quality of life-36 and the Center for Epidemiological Studies Depression Scale assessed various PROs. Moderate-to-extreme pruritus was defined as a Likert scale score ≥3. The associations of pruritus with PROs were assessed using linear/logistic regression where appropriate. Death or hemodialysis transfer was assessed using multivariable Cox regression models. RESULTS: Overall, 5535 patients from eight countries were included; 43% had moderate-to-extreme pruritus which was the highest in Thailand (50%) and the lowest in the United States (33%). The adjusted odds ratios of moderate-to-extreme pruritus were higher for diabetes, low albumin, and elevated phosphorus but lower for residual urine volume (adjusted odds ratio, 0.98 per 200 ml increase in 24-hour urine volume; 95% confidence interval, 0.96 to 1.00; P = 0.05). Patients with extreme pruritus had the lowest mental and physical health component scores and a higher burden of other PROs including restless legs and disturbed sleep. Overall, 921 patients died and 1150 were transferred to hemodialysis. Patients with moderate-to-extreme pruritus were at higher adjusted risk for death or hemodialysis transfer (adjusted hazard ratio, 1.12; 95% confidence interval, 1.02 to 1.23; P = 0.02) with similar point estimates for each subcomponent of the composite outcome. CONCLUSIONS: Pruritus is highly prevalent in PD and associated with poor health outcomes. Efforts to better identify and manage pruritus should be considered in this population.
引用
- Tennankore KK, McCullough K, Bieber B, et al. Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus: International Results from Peritoneal Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2024. PMID: 39652652. doi:10.2215/CJN.0000000000000537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。